Cargando…
From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers
Among the numerous oncogenes involved in human cancers, KRAS represents the most studied and best characterized cancer-related genes. Several therapeutic strategies targeting oncogenic KRAS (KRAS(onc)) signaling pathways have been suggested, including the inhibition of synthetic lethal interactions,...
Autores principales: | Saliani, Mahsa, Jalal, Razieh, Ahmadian, Mohammad Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743616/ https://www.ncbi.nlm.nih.gov/pubmed/31565476 http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0530 |
Ejemplares similares
-
Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells
por: Saliani, Mahsa, et al.
Publicado: (2022) -
KRAS-related long noncoding RNAs in human cancers
por: Saliani, Mahsa, et al.
Publicado: (2021) -
RHO GTPase-Related Long Noncoding RNAs in Human Cancers
por: Saliani, Mahsa, et al.
Publicado: (2021) -
Effects of pH and Temperature on Antibacterial Activity of Zinc Oxide Nanofluid Against Escherichia coli O157: H7 and Staphylococcus aureus
por: Saliani, Mahsa, et al.
Publicado: (2015) -
Targeting KRAS in Cancer: Promising Therapeutic Strategies
por: Mustachio, Lisa Maria, et al.
Publicado: (2021)